Cardioprotection by Recombinant Human Erythropoietin Following Acute Experimental Myocardial Infarction: Dose Response and Therapeutic Window

Author： Moon Chanil   Krawczyk Melissa   Paik Doojin   Lakatta Edward   Talan Mark  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.19, Iss.4, 2005-08, pp. : 243-250

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Effectiveness of a Single vs Multiple Doses of Erythropoietin After Experimental Myocardial Infarction in Rats

By Moon Chanil   Krawczyk Melissa   Lakatta Edward   Talan Mark  

Cardiovascular Drugs and Therapy, Vol. 20, Iss. 4, 2006-08 ,pp. : 245-251

Springer Publishing Company

Access to resources Recommend Favorite

Acetaminophen and Experimental Acute Myocardial Infarction

By Hale Sharon   Kloner Robert  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 2, 2004-03 ,pp. : 121-125

Springer Publishing Company

Access to resources Recommend Favorite

Therapeutic Potential of Monteplase in Acute Myocardial Infarction

By Inoue Teruo  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 4, 2005-01 ,pp. : 225-231

Adis International

Access to resources Recommend Favorite

Acute Myocardial Infarction During High-Dose Methylprednisolone therapy for Graves’ Ophthalmopathy

By Owecki Maciej   Sowiński Jerzy  

Pharmacy World and Science, Vol. 28, Iss. 2, 2006-04 ,pp. : 73-75

Springer Publishing Company

Access to resources Recommend Favorite

Tenecteplase: A Review of its Pharmacology and Therapeutic Efficacy in Patients with Acute Myocardial Infarction

By Dunn C.J.   Goa K.L.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 1, 2001-01 ,pp. : 51-66

Adis International

Access to resources Recommend Favorite